Evidence map›Paper›PMID 33245766›Full record

ArticleNucleic acids research2020

BCCIP is required for nucleolar recruitment of eIF6 and 12S pre-rRNA production during 60S ribosome biogenesis.

Caiyong Ye, Bochao Liu, Huimei Lu, Jingmei Liu, Arnold B Rabson, Estela Jacinto, Dimitri G Pestov, Zhiyuan Shen

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Multiomics Integrated Analysis IdentifiesJournal of diabetes research · 2022
    Article
  13. Article
  14. Article
  15. Structure of human BCCIP and implications for binding and modification of partner proteins.Protein science : a publication of the Protein Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Caiyong YeRutgers Cancer Institute of New Jersey, Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901, USA.
Bochao LiuRutgers Cancer Institute of New Jersey, Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901, USA.
Huimei LuRutgers Cancer Institute of New Jersey, Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901, USA.
Jingmei LiuRutgers Cancer Institute of New Jersey, Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901, USA.
Arnold B RabsonDepartment of Pharmacology, and The Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Estela JacintoDepartment of Biochemistry and Molecular Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Dimitri G PestovDepartment of Cell Biology and Neuroscience, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA.
Zhiyuan ShenRutgers Cancer Institute of New Jersey, Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901, USA.
Rutgers, The State University of New Jersey · USRowan University · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Molecular modulators of radiation-induced chromosome instability and hematopoietic damageR01CA195612 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SHEN, ZHIYUAN · 2015 to 2025
$3.6M
The Regulation of Cell Metabolism and Proliferation by mTOR complex 2R01GM079176 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI JACINTO, ESTELA · 2008 to 2017
$2.8M
Alternative Mechanisms to Inactivate p53 During OncogenesisR01CA156706 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI SHEN, ZHIYUAN · 2011 to 2015
$1.9M
Cotranslational Functions of MTORR01CA154674 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI JACINTO, ESTELA · 2012 to 2017
$1.8M
Nucleolar signaling in cancerR03CA246009 · NCI · ROWAN UNIVERSITY SCHOOL/OSTEOPATHIC MED · PI PESTOV, DIMITRI G · 2020 to 2021
$161k
NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA154674NCI NIH HHS R01 CA156706NCI NIH HHS R01 CA195612NCI NIH HHS R03 CA246009NIGMS NIH HHS R01 GM079176
6 · The paper itself

Abstract

Ribosome biogenesis is a fundamental process required for cell proliferation. Although evolutionally conserved, the mammalian ribosome assembly system is more complex than in yeasts. BCCIP was originally identified as a BRCA2 and p21 interacting protein. A partial loss of BCCIP function was sufficient to trigger genomic instability and tumorigenesis. However, a complete deletion of BCCIP arrested cell growth and was lethal in mice. Here, we report that a fraction of mammalian BCCIP localizes in the nucleolus and regulates 60S ribosome biogenesis. Both abrogation of BCCIP nucleolar localization and impaired BCCIP-eIF6 interaction can compromise eIF6 recruitment to the nucleolus and 60S ribosome biogenesis. BCCIP is vital for a pre-rRNA processing step that produces 12S pre-rRNA, a precursor to the 5.8S rRNA. However, a heterozygous Bccip loss was insufficient to impair 60S biogenesis in mouse embryo fibroblasts, but a profound reduction of BCCIP was required to abrogate its function in 60S biogenesis. These results suggest that BCCIP is a critical factor for mammalian pre-rRNA processing and 60S generation and offer an explanation as to why a subtle dysfunction of BCCIP can be tumorigenic but a complete depletion of BCCIP is lethal.

Indexed as

AnimalsBRCA2 ProteinCarcinogenesisCell Cycle ProteinsCell ProliferationCyclin-Dependent Kinase Inhibitor p21Eukaryotic Initiation FactorsFibroblastsGenomic InstabilityHumansMiceNIH 3T3 CellsProtein Interaction MapsRibosomesRibosome Subunits, Large, EukaryoticRNA, RibosomalBCCIP protein, mouseBRCA2 ProteinBRCA2 protein, humanCDKN1A protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21EIF6 protein, humanEukaryotic Initiation FactorsRNA, RibosomalRNA, ribosomal, 12SRNA, Ribosomal, 5.8S

Identifiers

PMID33245766
PMCPMC7736804
OpenAlexW3107368479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.